Paige Resor
Primary Care · Carthage, NCNPI 1588963482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novo Nordisk at 29.6% of the total. Reporting peaked in 2022 at $1,215 and has fallen 94.0% since, to $73 in 2025.
Across 145 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$839
- AbbVie$587
- Astellas Pharma US Inc$210
- Daiichi Sankyo Inc.$138
- Amgen$112
- Axonics, Inc.$106
- plus $846 from 21 others
What the payments were for
- Food & beverage$2,75297%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 51 | $839 |
| AbbVie | 25 | $587 |
| Astellas Pharma US Inc | 9 | $210 |
| Daiichi Sankyo Inc. | 7 | $138 |
| Amgen | 1 | $112 |
| Axonics, Inc. | 1 | $106 |
| Urovant Sciences Inc | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Mayne Pharma Commercial LLC | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Therapeuticsmd, Inc. | 3 | $54 |
| Pfizer | 3 | $54 |
| Bayer | 4 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Coopersurgical, Inc. | 2 | $42 |
| Exeltis, USA Inc. | 2 | $42 |
| Lupin Inc. | 2 | $32 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Tolmar, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Hologic Sales And Service, LLC | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $29 |
| Exact Sciences | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
- Saxenda$125
- EVENITY$112
- Axonics r-SNM System$106
How this compares
$2,837 in reported general payments places this provider in the 85th percentile of 236 primary care providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 54 | $1,653 |
| Estradiol (Twice Weekly)Estradiol | 15 | $972 |
| Liothyronine Sodium | 16 | $489 |
| Losartan Potassium | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Other primary care in Carthage
- Jessica AllynRaleigh$21K
- Jennifer RogersWinston Salem$17K
- Elizabeth WaltersChapel Hill$14K
- Ragan JohnsonChapel Hill$13K
- Kirkland DickeyPine Hall$11K
- Kimberly WeaverHickory$9K
- Amanda StoneWilmington$9K
- Elizabeth WalshGreensboro$7K
- Mark HollingsworthWilmington$7K
- Crystal GoinsFayetteville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.